注射吸毒者复杂性金黄色葡萄球菌菌血症部分口服抗生素治疗的结局
研究评估2016年1月至2021年12月住院、有注射吸毒史且合并感染性心内膜炎、硬膜外脓肿、椎体骨髓炎或化脓性关节炎等复杂性金黄色葡萄球菌血流感染的患者,按抗生素治疗方式比较出院后90天内死亡或微生物学失败再入院。初始静脉疗程未完成即出院者中,加用口服抗生素者发生微生物学失败或死亡的可能性显著低于未加用口服抗生素者(P<.001);接受至少10天静脉抗生素后转为部分口服者与标准静脉治疗者的微生物学失败率无显著差异(P>.9)。
要点
- 初始静脉疗程未完成即出院且不加口服抗生素者,微生物学失败或死亡风险高。
- 静脉疗程未完成出院后加用口服抗生素者,微生物学失败或死亡风险显著低于不加用者(P<.001)。
- 接受至少10天静脉抗生素后转部分口服者与标准静脉治疗者微生物学失败率无显著差异(P>.9)。
核心结论
- 对于静脉疗程未完成即出院的注射吸毒者复杂性金黄色葡萄球菌菌血症,不加口服抗生素出院会导致高发病率,应避免。
- 对已接受至少10天有效静脉抗生素且血培养清除后的患者,若患者不愿接受标准静脉治疗,转为口服并配合门诊支持是潜在替代方案。
研究设计与样本
- 评估2016年1月至2021年12月住院、有注射吸毒史、合并复杂性金黄色葡萄球菌血流感染(包括感染性心内膜炎、硬膜外脓肿、椎体骨髓炎和化脓性关节炎)的所有成年患者。
- 按抗生素治疗方式分为标准静脉抗生素、静脉疗程未完成、初始静脉转为部分口服三组进行比较。
- 主要复合终点为出院后90天内因微生物学失败导致的死亡或再入院。
主要发现
- 静脉疗程未完成出院后接受口服抗生素者,发生微生物学失败或死亡的可能性显著低于未接受口服抗生素出院者(P<.001)。
- 接受至少10天静脉抗生素后出院时转为部分口服者与标准静脉治疗方案者相比,微生物学失败率无显著差异(P>.9)。
临床怎么用
- 对已接受至少10天有效静脉抗生素且血培养已清除、但不愿接受标准静脉治疗的注射吸毒者复杂性金黄色葡萄球菌菌血症患者,作者认为转为口服抗生素并配合门诊支持是潜在替代方案。
- 作者认为,静脉疗程未完成即出院的注射吸毒者复杂性金黄色葡萄球菌菌血症患者不应不加口服抗生素出院。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Staphylococcus aureus represents the leading cause of complicated bloodstream infections among persons who inject drugs (PWID). Standard of care (SOC) intravenous (IV) antibiotics result in high rates of treatment success but are not feasible for some PWID. Transition to oral antibiotics may represent an alternative treatment option. METHODS: We evaluated all adult patients with a history of injection drug use hospitalized from January 2016 through December 2021 with complicated S. aureus bloodstream infections, including infective endocarditis, epidural abscess, vertebral osteomyelitis, and septic arthritis. Patients were compared by antibiotic treatment (standard of care intravenous [SOC IV] antibiotics, incomplete IV therapy, or transition from initial IV to partial oral) using the primary composite endpoint of death or readmission from microbiologic failure within 90 days of discharge. RESULTS: Patients who received oral antibiotics after an incomplete IV antibiotic course were significantly less likely to experience microbiologic failure or death than patients discharged without oral antibiotics (P < .001). There was no significant difference in microbiologic failure rates when comparing patients who were discharged on partial oral antibiotics after receiving at least 10 days of IV antibiotics with SOC regimens (P > .9). CONCLUSIONS: Discharge of PWID with partially treated complicated S. aureus bacteremias without oral antibiotics results in high rates of morbidity and should be avoided. For PWID hospitalized with complicated S. aureus bacteremias who have received at least 10 days of effective IV antibiotic therapy after clearance of bacteremia, transition to oral antibiotics with outpatient support represents a potential alternative if the patient does not desire SOC IV antibiotic therapy.
引用
- Wildenthal JA, Atkinson A, Lewis S, et al. Outcomes of Partial Oral Antibiotic Treatment for Complicated Staphylococcus aureus Bacteremia in People Who Inject Drugs. Clin Infect Dis. 2023. PMID: 36052413. doi:10.1093/cid/ciac714
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。